291 related articles for article (PubMed ID: 22075790)
1. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.
Castagnini LA; Healy CM; Rench MA; Wootton SH; Munoz FM; Baker CJ
Clin Infect Dis; 2012 Jan; 54(1):78-84. PubMed ID: 22075790
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection.
Healy CM; Rench MA; Wootton SH; Castagnini LA
Pediatr Infect Dis J; 2015 Jan; 34(1):22-6. PubMed ID: 24992123
[TBL] [Abstract][Full Text] [Related]
3. Implementation of cocooning against pertussis in a high-risk population.
Healy CM; Rench MA; Baker CJ
Clin Infect Dis; 2011 Jan; 52(2):157-62. PubMed ID: 21288837
[TBL] [Abstract][Full Text] [Related]
4. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
Healy CM; Rench MA; Baker CJ
Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
[TBL] [Abstract][Full Text] [Related]
5. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
6. Pertussis immunization in a high-risk postpartum population.
Healy CM; Rench MA; Castagnini LA; Baker CJ
Vaccine; 2009 Sep; 27(41):5599-602. PubMed ID: 19647062
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial.
Munoz FM; Bond NH; Maccato M; Pinell P; Hammill HA; Swamy GK; Walter EB; Jackson LA; Englund JA; Edwards MS; Healy CM; Petrie CR; Ferreira J; Goll JB; Baker CJ
JAMA; 2014 May; 311(17):1760-9. PubMed ID: 24794369
[TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.
Terranella A; Asay GR; Messonnier ML; Clark TA; Liang JL
Pediatrics; 2013 Jun; 131(6):e1748-56. PubMed ID: 23713104
[TBL] [Abstract][Full Text] [Related]
10. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
[TBL] [Abstract][Full Text] [Related]
11. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1424-6. PubMed ID: 22012116
[TBL] [Abstract][Full Text] [Related]
12. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants.
Winter K; Cherry JD; Harriman K
Clin Infect Dis; 2017 Jan; 64(1):9-14. PubMed ID: 27624956
[TBL] [Abstract][Full Text] [Related]
14. Association of postpartum maternal tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine administration and timeliness of infant immunization.
Kaur I; George KJ; Pena-Ricardo C; Kelly BA; Watson B
Pediatr Infect Dis J; 2013 Nov; 32(11):1287-9. PubMed ID: 23694833
[TBL] [Abstract][Full Text] [Related]
15. Hospital-acquired pertussis among newborns--Texas, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(22):600-3. PubMed ID: 18528316
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.
Winter K; Nickell S; Powell M; Harriman K
Clin Infect Dis; 2017 Jan; 64(1):3-8. PubMed ID: 27624955
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of acceleration of the pertussis vaccine primary series for infants.
Shinall MC; Peters TR; Zhu Y; Chen Q; Poehling KA
Pediatrics; 2008 Nov; 122(5):1021-6. PubMed ID: 18977982
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.
Halperin BA; Morris A; Mackinnon-Cameron D; Mutch J; Langley JM; McNeil SA; Macdougall D; Halperin SA
Clin Infect Dis; 2011 Nov; 53(9):885-92. PubMed ID: 21946190
[TBL] [Abstract][Full Text] [Related]
19. Tetanus, diphtheria, and acellular pertussis vaccination during pregnancy and reduced risk of infant acute respiratory infections.
Khodr ZG; Bukowinski AT; Gumbs GR; Conlin AMS
Vaccine; 2017 Oct; 35(42):5603-5610. PubMed ID: 28916245
[TBL] [Abstract][Full Text] [Related]
20. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
Dylag AM; Shah SI
Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
